24 August 2026
Leqembi Iqlik autoinjector available in the US
Eisai said the FDA-approved subcutaneous injection is now on the market for initiation therapy in early Alzheimer’s disease.
The full briefing is in the app.
24 August 2026
Eisai said the FDA-approved subcutaneous injection is now on the market for initiation therapy in early Alzheimer’s disease.
The full briefing is in the app.